Clinical trials
Waldenstrom Macroglobulinemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acerta Pharma BV | 1 |
| BeiGene | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Janssen Research & Development, LLC | 1 |
| Kite, A Gilead Company | 1 |
| Meletios A. Dimopoulos | 1 |
| Nurix Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Burkitt Lymphoma | 2 |
| Leukemia, Hairy Cell | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Recurrence | 2 |
Trials
Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.